共 234 条
- [1] Bakayev VV(2004)Arylamine Eur J Clin Pharmacol 60 467-471
- [2] Mohammadi F(2000)-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals Mov Disord 15 30-35
- [3] Bahadori M(1993)Detailed genotyping demonstrates association between the slow acetylator genotype for Carcinogenesis 14 1689-1692
- [4] Sheikholslami M(1990)-acetyltransferase 2 (NAT2) and familial Parkinson’s disease DNA Cell Biol 9 193-203
- [5] Javeri A(1991)Genotype/phenotype discordance for human arylamine Proc Natl Acad Sci USA 88 5237-5241
- [6] Masjedi MR(2002)-acetyltransferase 2 (NAT2) reveals a new slow-acetylator allele common in African–Americans Pharmacogenomics J 2 30-42
- [7] Velayati AA(1995)Human Am J Hum Genet 57 581-592
- [8] Bandmann O(2006)-acetyltransferase genes: isolation, chromosomal localisation and functional expression Eur J Clin Pharmacol 62 355-359
- [9] Vaughan JR(2001)Molecular mechanism of slow acetylation of drugs and carcinogens in humans Drug Metab Dispos 29 606-610
- [10] Holmans P(1999)Pharmacogenetics of the arylamine Cancer Epidemiol Biomarkers Prev 8 683-692